Wilmington, MA, United States of America

Priscilla Jennings



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Priscilla Jennings: Innovator in Protein Purification

Introduction

Priscilla Jennings is a notable inventor based in Wilmington, MA, recognized for her contributions in the field of biotechnology. With a focus on the purification of proteins, her work has significant implications for the development and enhancement of pharmaceuticals.

Latest Patents

Priscilla holds a patent for the "Purification of acidic proteins using ceramic hydroxyapatite chromatography." This innovative method addresses the challenge of removing product-related inactive or partially active species, as well as high molecular weight aggregates and other impurities from preparations of acidic proteins. The use of ceramic hydroxyapatite chromatography in her technique represents a valuable advancement in the purification processes utilized in biopharmaceuticals.

Career Highlights

Priscilla Jennings is associated with Wyeth, a leading biopharmaceutical company that focuses on developing innovative medicines. Her role involves applying her expertise in protein chemistry to improve product quality and efficacy in the pharmaceutical sector. Her patent underscores her commitment to enhancing purification methodologies, which is crucial in ensuring the safety and effectiveness of therapeutic proteins.

Collaborations

Throughout her career, Priscilla has collaborated with esteemed colleagues, including Shujun Sun and Yin Luo. These collaborations have enriched her research and innovation efforts, driving forward the frontiers of biopharmaceutical development.

Conclusion

Priscilla Jennings' pioneering work in protein purification exemplifies the impact of innovation in the biopharmaceutical industry. Through her patented methods, she contributes significantly to the quality of therapeutic proteins, ultimately benefiting pharmaceutical advancements and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…